Cargando…
Dual-labeled nanoparticles based on small extracellular vesicles for tumor detection
BACKGROUND: Small extracellular vesicles (sEVs) are emerging natural nanoplatforms in cancer diagnosis and therapy, through the incorporation of signal components or drugs in their structure. However, for their translation into the clinical field, there is still a lack of tools that enable a deeper...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664624/ https://www.ncbi.nlm.nih.gov/pubmed/36376978 http://dx.doi.org/10.1186/s13062-022-00345-7 |
_version_ | 1784831139976839168 |
---|---|
author | Santos-Coquillat, Ana Herreros-Pérez, Desiré Samaniego, Rafael González, María Isabel Cussó, Lorena Desco, Manuel Salinas, Beatriz |
author_facet | Santos-Coquillat, Ana Herreros-Pérez, Desiré Samaniego, Rafael González, María Isabel Cussó, Lorena Desco, Manuel Salinas, Beatriz |
author_sort | Santos-Coquillat, Ana |
collection | PubMed |
description | BACKGROUND: Small extracellular vesicles (sEVs) are emerging natural nanoplatforms in cancer diagnosis and therapy, through the incorporation of signal components or drugs in their structure. However, for their translation into the clinical field, there is still a lack of tools that enable a deeper understanding of their in vivo pharmacokinetics or their interactions with the cells of the tumor microenvironment. In this study, we have designed a dual-sEV probe based on radioactive and fluorescent labeling of goat milk sEVs. RESULTS: The imaging nanoprobe was tested in vitro and in vivo in a model of glioblastoma. In vitro assessment of the uptake of the dual probe in different cell populations (RAW 264.7, U87, and HeLa) by optical and nuclear techniques (gamma counter, confocal imaging, and flow cytometry) revealed the highest uptake in inflammatory cells (RAW 264.7), followed by glioblastoma U87 cells. In vivo evaluation of the pharmacokinetic properties of nanoparticles confirmed a blood circulation time of ~ 8 h and primarily hepatobiliary elimination. The diagnostic capability of the dual nanoprobe was confirmed in vivo in a glioblastoma xenograft model, which showed intense in vivo uptake of the SEV-based probe in tumor tissue. Histological assessment by confocal imaging enabled quantification of tumor populations and confirmed uptake in tumor cells and tumor-associated macrophages, followed by cancer-associated fibroblasts and endothelial cells. CONCLUSIONS: We have developed a chemical approach for dual radioactive and fluorescent labeling of sEVs. This methodology enables in vivo and in vitro study of these vesicles after exogenous administration. The dual nanoprobe would be a promising technology for cancer diagnosis and a powerful tool for studying the biological behavior of these nanosystems for use in drug delivery. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13062-022-00345-7. |
format | Online Article Text |
id | pubmed-9664624 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96646242022-11-15 Dual-labeled nanoparticles based on small extracellular vesicles for tumor detection Santos-Coquillat, Ana Herreros-Pérez, Desiré Samaniego, Rafael González, María Isabel Cussó, Lorena Desco, Manuel Salinas, Beatriz Biol Direct Research BACKGROUND: Small extracellular vesicles (sEVs) are emerging natural nanoplatforms in cancer diagnosis and therapy, through the incorporation of signal components or drugs in their structure. However, for their translation into the clinical field, there is still a lack of tools that enable a deeper understanding of their in vivo pharmacokinetics or their interactions with the cells of the tumor microenvironment. In this study, we have designed a dual-sEV probe based on radioactive and fluorescent labeling of goat milk sEVs. RESULTS: The imaging nanoprobe was tested in vitro and in vivo in a model of glioblastoma. In vitro assessment of the uptake of the dual probe in different cell populations (RAW 264.7, U87, and HeLa) by optical and nuclear techniques (gamma counter, confocal imaging, and flow cytometry) revealed the highest uptake in inflammatory cells (RAW 264.7), followed by glioblastoma U87 cells. In vivo evaluation of the pharmacokinetic properties of nanoparticles confirmed a blood circulation time of ~ 8 h and primarily hepatobiliary elimination. The diagnostic capability of the dual nanoprobe was confirmed in vivo in a glioblastoma xenograft model, which showed intense in vivo uptake of the SEV-based probe in tumor tissue. Histological assessment by confocal imaging enabled quantification of tumor populations and confirmed uptake in tumor cells and tumor-associated macrophages, followed by cancer-associated fibroblasts and endothelial cells. CONCLUSIONS: We have developed a chemical approach for dual radioactive and fluorescent labeling of sEVs. This methodology enables in vivo and in vitro study of these vesicles after exogenous administration. The dual nanoprobe would be a promising technology for cancer diagnosis and a powerful tool for studying the biological behavior of these nanosystems for use in drug delivery. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13062-022-00345-7. BioMed Central 2022-11-14 /pmc/articles/PMC9664624/ /pubmed/36376978 http://dx.doi.org/10.1186/s13062-022-00345-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Santos-Coquillat, Ana Herreros-Pérez, Desiré Samaniego, Rafael González, María Isabel Cussó, Lorena Desco, Manuel Salinas, Beatriz Dual-labeled nanoparticles based on small extracellular vesicles for tumor detection |
title | Dual-labeled nanoparticles based on small extracellular vesicles for tumor detection |
title_full | Dual-labeled nanoparticles based on small extracellular vesicles for tumor detection |
title_fullStr | Dual-labeled nanoparticles based on small extracellular vesicles for tumor detection |
title_full_unstemmed | Dual-labeled nanoparticles based on small extracellular vesicles for tumor detection |
title_short | Dual-labeled nanoparticles based on small extracellular vesicles for tumor detection |
title_sort | dual-labeled nanoparticles based on small extracellular vesicles for tumor detection |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664624/ https://www.ncbi.nlm.nih.gov/pubmed/36376978 http://dx.doi.org/10.1186/s13062-022-00345-7 |
work_keys_str_mv | AT santoscoquillatana duallabelednanoparticlesbasedonsmallextracellularvesiclesfortumordetection AT herrerosperezdesire duallabelednanoparticlesbasedonsmallextracellularvesiclesfortumordetection AT samaniegorafael duallabelednanoparticlesbasedonsmallextracellularvesiclesfortumordetection AT gonzalezmariaisabel duallabelednanoparticlesbasedonsmallextracellularvesiclesfortumordetection AT cussolorena duallabelednanoparticlesbasedonsmallextracellularvesiclesfortumordetection AT descomanuel duallabelednanoparticlesbasedonsmallextracellularvesiclesfortumordetection AT salinasbeatriz duallabelednanoparticlesbasedonsmallextracellularvesiclesfortumordetection |